Ex-BMS exec meets deadline for judge-ordered book

Former Bristol-Myers Squibb executive Andrew Bodnar, ordered by a U.S. judge to write a book as part of his sentence for deceiving the federal government about a patent settlement, has met the deadline for a preliminary draft. Report

Suggested Articles

Johnson & Johnson and Bayer’s Xarelto is working to reverse a sales slide, and a new indication could help.

AZ's FluMist will be dramatically limited in the U.S. this flu season because of production problems, a spokeswoman said.

To get its $12 billion opioid deal off the ground, Purdue Pharma pushed for a stay on thousands of lawsuits against it. Last week, a judge signed off.